Azenta, Inc. (AZTA)
USD 36.12
(-3.6%)
USD 36.12
(-3.6%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.25 Million USD | -26.32% |
| 2022 | -11.28 Million USD | 60.91% |
| 2021 | -28.86 Million USD | -144.51% |
| 2020 | 64.85 Million USD | 555.74% |
| 2019 | 9.89 Million USD | -91.52% |
| 2018 | 116.57 Million USD | 86.19% |
| 2017 | 62.61 Million USD | 190.12% |
| 2016 | -69.47 Million USD | -588.55% |
| 2015 | 14.22 Million USD | -54.65% |
| 2014 | 31.36 Million USD | 1515.85% |
| 2013 | -2.21 Million USD | -101.62% |
| 2012 | 136.78 Million USD | 6.57% |
| 2011 | 128.35 Million USD | 117.61% |
| 2010 | 58.98 Million USD | 125.89% |
| 2009 | -227.85 Million USD | 3.43% |
| 2008 | -235.94 Million USD | -255.77% |
| 2007 | 151.47 Million USD | 484.16% |
| 2006 | 25.93 Million USD | 357.83% |
| 2005 | -10.05 Million USD | -156.75% |
| 2004 | 17.72 Million USD | 109.54% |
| 2003 | -185.76 Million USD | 74.2% |
| 2002 | -719.95 Million USD | -2327.36% |
| 2001 | -29.66 Million USD | -332.57% |
| 2000 | 12.75 Million USD | 261.43% |
| 1999 | -7.9 Million USD | 57.07% |
| 1998 | -18.4 Million USD | -2400.0% |
| 1997 | 800 Thousand USD | -90.59% |
| 1996 | 8.5 Million USD | 84.78% |
| 1995 | 4.6 Million USD | 206.67% |
| 1994 | 1.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -15.72 Million USD | -565.9% |
| 2024 Q3 | -6.58 Million USD | 95.19% |
| 2024 Q2 | -136.88 Million USD | -770.52% |
| 2023 Q3 | -1.47 Million USD | 26.17% |
| 2023 FY | -14.25 Million USD | -26.32% |
| 2023 Q1 | -11.23 Million USD | -111.58% |
| 2023 Q4 | 3.37 Million USD | 329.59% |
| 2023 Q2 | -1.99 Million USD | 82.28% |
| 2022 Q2 | -1.81 Million USD | -104.19% |
| 2022 FY | -11.28 Million USD | 60.91% |
| 2022 Q1 | 43.32 Million USD | 98.68% |
| 2022 Q4 | -5.31 Million USD | 24.31% |
| 2022 Q3 | -7.01 Million USD | -286.29% |
| 2021 Q2 | 23.74 Million USD | -8.76% |
| 2021 FY | -28.86 Million USD | -144.51% |
| 2021 Q4 | 21.8 Million USD | -44.33% |
| 2021 Q3 | 39.16 Million USD | 64.92% |
| 2021 Q1 | 26.02 Million USD | -10.16% |
| 2020 Q4 | 28.97 Million USD | 111.54% |
| 2020 Q1 | 13.05 Million USD | -96.84% |
| 2020 Q3 | 13.69 Million USD | 50.06% |
| 2020 FY | 64.85 Million USD | 555.74% |
| 2020 Q2 | 9.12 Million USD | -30.1% |
| 2019 Q4 | 412.66 Million USD | 5588.76% |
| 2019 Q1 | 14.41 Million USD | 39.26% |
| 2019 Q3 | 7.25 Million USD | 112.04% |
| 2019 Q2 | 3.42 Million USD | -76.27% |
| 2019 FY | 9.89 Million USD | -91.52% |
| 2018 Q2 | 67.02 Million USD | 306.53% |
| 2018 FY | 116.57 Million USD | 86.19% |
| 2018 Q1 | 16.48 Million USD | -5.18% |
| 2018 Q3 | 22.71 Million USD | -66.1% |
| 2018 Q4 | 10.35 Million USD | -54.44% |
| 2017 FY | 62.61 Million USD | 190.12% |
| 2017 Q3 | 17.35 Million USD | 23.88% |
| 2017 Q4 | 17.38 Million USD | 0.21% |
| 2017 Q2 | 14 Million USD | 0.97% |
| 2017 Q1 | 13.87 Million USD | 31.52% |
| 2016 FY | -69.47 Million USD | -588.55% |
| 2016 Q3 | 8.56 Million USD | 110.2% |
| 2016 Q2 | -83.93 Million USD | -1705.92% |
| 2016 Q1 | -4.64 Million USD | -170.82% |
| 2016 Q4 | 10.54 Million USD | 23.16% |
| 2015 FY | 14.22 Million USD | -54.65% |
| 2015 Q3 | 7.68 Million USD | 183.33% |
| 2015 Q2 | 2.71 Million USD | 199.16% |
| 2015 Q4 | 6.56 Million USD | -14.56% |
| 2015 Q1 | -2.73 Million USD | -1202.42% |
| 2014 Q1 | 3.44 Million USD | -42.68% |
| 2014 Q2 | 3.18 Million USD | -7.51% |
| 2014 Q4 | 248 Thousand USD | -98.99% |
| 2014 Q3 | 24.47 Million USD | 667.51% |
| 2014 FY | 31.36 Million USD | 1515.85% |
| 2013 Q2 | -538 Thousand USD | 94.17% |
| 2013 FY | -2.21 Million USD | -101.62% |
| 2013 Q4 | 6.01 Million USD | 289.57% |
| 2013 Q3 | 1.54 Million USD | 386.99% |
| 2013 Q1 | -9.23 Million USD | -107.95% |
| 2012 Q2 | 9.48 Million USD | 216.41% |
| 2012 Q3 | 8.02 Million USD | -15.37% |
| 2012 Q4 | 116.21 Million USD | 1347.65% |
| 2012 FY | 136.78 Million USD | 6.57% |
| 2012 Q1 | 2.99 Million USD | -75.22% |
| 2011 Q2 | 26.58 Million USD | 13.2% |
| 2011 FY | 128.35 Million USD | 117.61% |
| 2011 Q4 | 12.09 Million USD | -81.72% |
| 2011 Q1 | 23.48 Million USD | -2.85% |
| 2011 Q3 | 66.18 Million USD | 148.95% |
| 2010 Q1 | -2.79 Million USD | 80.71% |
| 2010 FY | 58.98 Million USD | 125.89% |
| 2010 Q2 | 21.02 Million USD | 852.38% |
| 2010 Q3 | 16.57 Million USD | -21.19% |
| 2010 Q4 | 24.17 Million USD | 45.88% |
| 2009 FY | -227.85 Million USD | 3.43% |
| 2009 Q4 | -14.49 Million USD | 43.71% |
| 2009 Q3 | -25.74 Million USD | 83.12% |
| 2009 Q1 | -35.08 Million USD | 83.75% |
| 2009 Q2 | -152.54 Million USD | -334.81% |
| 2008 FY | -235.94 Million USD | -255.77% |
| 2008 Q4 | -215.9 Million USD | -1990.92% |
| 2008 Q3 | -10.32 Million USD | -19.18% |
| 2008 Q2 | -8.66 Million USD | -510.57% |
| 2008 Q1 | -1.41 Million USD | -9.74% |
| 2007 FY | 151.47 Million USD | 484.16% |
| 2007 Q4 | -1.29 Million USD | -105.66% |
| 2007 Q3 | 22.83 Million USD | -78.81% |
| 2007 Q2 | 107.78 Million USD | 386.86% |
| 2007 Q1 | 22.13 Million USD | 37.37% |
| 2006 Q1 | -11.21 Million USD | -47.3% |
| 2006 FY | 25.93 Million USD | 357.83% |
| 2006 Q3 | 17.16 Million USD | 294.35% |
| 2006 Q2 | 4.35 Million USD | 138.79% |
| 2006 Q4 | 16.11 Million USD | -6.09% |
| 2005 Q3 | 926 Thousand USD | 137.46% |
| 2005 Q1 | -895 Thousand USD | -111.15% |
| 2005 FY | -10.05 Million USD | -156.75% |
| 2005 Q4 | -7.61 Million USD | -922.46% |
| 2005 Q2 | -2.47 Million USD | -176.2% |
| 2004 Q2 | 6.23 Million USD | 170.27% |
| 2004 Q4 | 8.03 Million USD | -34.86% |
| 2004 Q1 | -8.86 Million USD | 82.1% |
| 2004 Q3 | 12.32 Million USD | 97.82% |
| 2004 FY | 17.72 Million USD | 109.54% |
| 2003 Q1 | -70.98 Million USD | 89.46% |
| 2003 FY | -185.76 Million USD | 74.2% |
| 2003 Q4 | -49.53 Million USD | -35.97% |
| 2003 Q3 | -36.43 Million USD | -26.5% |
| 2003 Q2 | -28.8 Million USD | 59.43% |
| 2002 FY | -719.95 Million USD | -2327.36% |
| 2002 Q1 | -7.73 Million USD | 76.01% |
| 2002 Q2 | -11.7 Million USD | -51.31% |
| 2002 Q3 | -24.19 Million USD | -106.78% |
| 2002 Q4 | -673.29 Million USD | -2682.56% |
| 2001 Q2 | -2.7 Million USD | -154.29% |
| 2001 Q4 | -32.24 Million USD | -10705.26% |
| 2001 Q3 | 304 Thousand USD | 111.25% |
| 2001 FY | -29.66 Million USD | -332.57% |
| 2001 Q1 | 4.97 Million USD | -7.63% |
| 2000 Q4 | 5.39 Million USD | 116.81% |
| 2000 Q1 | 2.9 Million USD | 137.66% |
| 2000 Q3 | 2.48 Million USD | 71.21% |
| 2000 Q2 | 1.45 Million USD | -49.93% |
| 2000 FY | 12.75 Million USD | 261.43% |
| 1999 FY | -7.9 Million USD | 57.07% |
| 1999 Q4 | -7.7 Million USD | -2666.67% |
| 1999 Q3 | 300 Thousand USD | 200.0% |
| 1999 Q2 | 100 Thousand USD | 116.67% |
| 1999 Q1 | -600 Thousand USD | 95.59% |
| 1998 Q2 | -3.8 Million USD | -1800.0% |
| 1998 Q1 | -200 Thousand USD | -110.0% |
| 1998 FY | -18.4 Million USD | -2400.0% |
| 1998 Q4 | -13.6 Million USD | -1600.0% |
| 1998 Q3 | -800 Thousand USD | 78.95% |
| 1997 Q3 | 300 Thousand USD | 120.0% |
| 1997 Q2 | -1.5 Million USD | 0.0% |
| 1997 Q4 | 2 Million USD | 566.67% |
| 1997 FY | 800 Thousand USD | -90.59% |
| 1997 Q1 | - USD | -100.0% |
| 1996 Q4 | 2.2 Million USD | -8.33% |
| 1996 FY | 8.5 Million USD | 84.78% |
| 1996 Q3 | 2.4 Million USD | 14.29% |
| 1996 Q2 | 2.1 Million USD | 23.53% |
| 1996 Q1 | 1.7 Million USD | -5.56% |
| 1995 FY | 4.6 Million USD | 206.67% |
| 1995 Q4 | 1.8 Million USD | 38.46% |
| 1995 Q2 | 900 Thousand USD | 28.57% |
| 1995 Q3 | 1.3 Million USD | 44.44% |
| 1995 Q1 | 700 Thousand USD | 0.0% |
| 1994 FY | 1.5 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 77.485% |
| AngioDynamics, Inc. | -184.34 Million USD | 92.266% |
| AtriCure, Inc. | -30.43 Million USD | 53.161% |
| Avinger, Inc. | -18.32 Million USD | 22.178% |
| BioLife Solutions, Inc. | -66.42 Million USD | 78.537% |
| The Cooper Companies, Inc. | 294.2 Million USD | 104.846% |
| Daxor Corporation | 280.64 Thousand USD | 5180.174% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 6.192% |
| Femasys Inc. | -14.24 Million USD | -0.069% |
| GlucoTrack, Inc. | -7.09 Million USD | -100.888% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -317.482% |
| Hologic, Inc. | 789.5 Million USD | 101.806% |
| ICU Medical, Inc. | -29.65 Million USD | 51.924% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.793% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -3.755% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 147.358% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -113.959% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -113.959% |
| Masimo Corporation | 81.5 Million USD | 117.493% |
| Microbot Medical Inc. | -10.74 Million USD | -32.747% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 222.636% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 115.101% |
| Nephros, Inc. | -1.57 Million USD | -805.206% |
| NovoCure Limited | -207.04 Million USD | 93.114% |
| NEXGEL, Inc. | -3.15 Million USD | -351.6% |
| NEXGEL, Inc. | -3.15 Million USD | -351.6% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 84.964% |
| OraSure Technologies, Inc. | 53.65 Million USD | 126.572% |
| Pro-Dex, Inc. | 2.12 Million USD | 770.287% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 66.224% |
| Predictive Oncology Inc. | -13.98 Million USD | -1.952% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -383.063% |
| QuidelOrtho Corporation | -10.1 Million USD | -41.158% |
| Repligen Corporation | 41.57 Million USD | 134.291% |
| Sanara MedTech Inc. | -4.3 Million USD | -231.312% |
| STAAR Surgical Company | 21.34 Million USD | 166.787% |
| Sharps Technology, Inc. | -9.84 Million USD | -44.864% |
| Utah Medical Products, Inc. | 16.63 Million USD | 185.705% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 89.199% |
| Jin Medical International Ltd. | 2.87 Million USD | 595.339% |